Toxicity and Survival After Intensity-Modulated Proton Therapy Versus Passive Scattering Proton Therapy for NSCLC-Reference-Cited by-同舟云学术

Toxicity and Survival After Intensity-Modulated Proton Therapy Versus Passive Scattering Proton Therapy for NSCLC

Published:2021-02 Issue:2 Volume:16 Page:269-277
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Gjyshi Olsi^ORCID,Xu Ting,Elhammali Adnan,Boyce-Fappiano David,Chun Stephen G.,Gandhi Saumil,Lee Percy,Chen Aileen B.,Lin Steven H.,Chang Joe Y.,Tsao Anne,Gay Carl M.,Zhu X. Ronald,Zhang Xiaodong,Heymach John V.,Fossella Frank V.,Lu Charles,Nguyen Quynh-Nhu,Liao Zhongxing

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference19 articles.

1. Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC;Antonia;N Engl J Med,2018

2. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer;Antonia;N Engl J Med,2017

3. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

4. Cardiac toxicity after radiotherapy for stage III non-small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy;Wang;J Clin Oncol,2017

5. Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: a secondary analysis of the NRG oncology RTOG 0617 randomized clinical trial;Chun;J Clin Oncol,2017

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Moving beyond mean heart dose: The importance of cardiac substructures in radiation therapy toxicity;Journal of Medical Imaging and Radiation Oncology;2024-09-03

2. ACR-ARS Practice Parameter for the Performance of Proton Beam Therapy;International Journal of Particle Therapy;2024-09

3. Exploring treatment options in cancer: tumor treatment strategies;Signal Transduction and Targeted Therapy;2024-07-17

4. A Pilot Trial of Proton-Based Cardiac Sparing Accelerated Fractionated Radiation Therapy in Unresectable Non-small Cell Lung Cancer With Extended Durvalumab Therapy (PARTICLE-D);Practical Radiation Oncology;2024-07

5. Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinoma;Radiotherapy and Oncology;2024-04